Skip to main content

3 Result(s)

within Hiroko Kiyomatsu Remove this filter

and

  1. Article

    Open Access

    High expression of soluble CD155 in estrogen receptor-negative breast cancer

    The poliovirus receptor (CD155) is expressed ubiquitously at low levels on both hematopoietic and nonhematopoietic cells, but its expression is upregulated in various tumor cells. An activating receptor DNAM-1...

    Akiko Iguchi-Manaka, Genki Okumura, Emika Ichioka, Hiroko Kiyomatsu… in Breast Cancer (2020)

    Download PDF (744 KB) View Article

  2. No Access

    Article

    A case of hemorrhagic cystitis caused by nab-paclitaxel

    Nab-paclitaxel (nab-PTX) is a nanoparticle albumin-bound paclitaxel and, as such, is free of solvents like ethanol and polyoxyethylene castor oil. The absence of solvents from this formulation has several prac...

    Emika Ichioka, Akiko Iguchi-Manaka… in International Cancer Conference Journal (2016)

  3. No Access

    Article

    Extreme response to nab-paclitaxel and trastuzumab treatment in two patients with locally advanced or recurrent breast cancer

    Nab-paclitaxel is a novel nanoparticle, albumin-bound paclitaxel that is free of solvents. The absence of solvents allows nab-paclitaxel to be administered without the premedication used routinely for the prev...

    Hiroko Kiyomatsu, Yuko Tanaka, Tatsuhiko Ikeda… in International Cancer Conference Journal (2014)